QNRX
Quoin Pharmaceuticals, Ltd.
Industry
Biotechnology
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Loading...
Open
0.71
Mkt cap
3.6M
Volume
170K
High
0.71
P/E Ratio
-0.19
52-wk high
6.18
Low
0.66
Div yield
N/A
52-wk low
0.48

Portfolio Pulse from Benzinga Newsdesk
October 18, 2024 | 3:33 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.